This compound is a promising natural inhibitor that could potentially be used to target HIF-1α-overexpressing cancer cells or combine with other endocrine therapies to reduce drug resistance or recurrence of hormone-dependent breast cancer. The gene discussed is HIF1A; the disease is cancer.